Massachusetts Institute of Technology
Chemprop
A family is a named generation or product line. Scores below are the sum of its named releases and any documented internal systems in the same line.
Benefit
+0.43
Harm
0.00
Net Good
0.43
Releases
- Chemprop-style Internal Research ModelInternal / unreleased
- Chemprop Ensemble Internal Research ModelInternal / unreleased
Leaderboard
| Rank | Model | Organization | Benefit | Harm | Net | Events | Last impact |
|---|---|---|---|---|---|---|---|
| 48 | Chemprop Ensemble Internal Research Model Chemprop · internal / unreleased | Massachusetts Institute of Technology | +0.35 | 0.00 | 0.35 | 1 | 20 Dec 2023 |
| 61 | Chemprop-style Internal Research Model Chemprop · internal / unreleased | Massachusetts Institute of Technology | +0.08 | 0.00 | 0.08 | 1 | 25 May 2023 |
Timeline
- Benefit
- Harm
- Net
Events
Benefit20 Dec 2023
Explainable graph networks identify a new MRSA-active antibiotic class
MIT and Broad researchers used ensembles of graph neural networks over 12 million compounds to find a structural class active against MRSA and VRE in mice, published 20 December 2023 in Nature.
Medicine & HealthverifiedTier 3 Major+0.35
Benefit25 May 2023
Deep learning identifies abaucin, a narrow-spectrum Acinetobacter antibiotic
MIT and McMaster researchers trained a neural net on in-vitro growth data and identified abaucin, which killed A. baumannii in culture and a mouse wound model, published 25 May 2023.
Medicine & HealthverifiedTier 2 Notable+0.08